Compartilhar
Informação da revista
Conteúdo especial sobre o coronavírus SARS-CoV-2 (COVID-19) em Hematology, Transfusion and Cell Therapy
ESTOQUE DE SANGUE E SEUS DESAFIOS DURANTE A PANDEMIA DE COVID-19
DH Silva, ARC Barbosa, EJS Ferreira, KT Castellano, LV Pucci, LMB Silva, LS Oliveira
10.1016/j.htct.2022.09.647
Hematol Transfus Cell Ther. 2022;44 Supl 2:S382-3
Open access
PERFIL DOS CANDIDATOS À DOAÇÃO DE SANGUE APÓS PICO A PANDEMIA DA COVID-19
RA Bento, APC Rodrigues, APC Sessin, ACA Pitol, JED Giacomo, JAD Santos, DE Rossetto
10.1016/j.htct.2022.09.669
Hematol Transfus Cell Ther. 2022;44 Supl 2:S395-6
Open access
DOAÇÕES DE SANGUE NO HEMOCENTRO REGIONAL DE SANTA MARIA: A INFLUÊNCIA DA PANDEMIA DA COVID-19 NA CAPTAÇÃO DE DOADORES ESTÁ ACABANDO?
AG Vilanova, JVP Gonçalves, LC Souza, FZ Lima, ISO Tioda, ABD Santos, PG Schimites
10.1016/j.htct.2022.09.675
Hematol Transfus Cell Ther. 2022;44 Supl 2:S398-9
Open access
IMPACTO DA PANDEMIA DA COVID-19 NAS DOAÇÕES DE SANGUE TOTAL E AFÉRESE NO HEMOCENTRO COORDENADOR DO PARANÁ
EDA Cruz, MZ Covo, R Pavese, LS Grigoletti, OO Luz, S Onofre, S Silva
10.1016/j.htct.2022.09.674
Hematol Transfus Cell Ther. 2022;44 Supl 2:S398
Open access
IDENTIFICAÇÃO DE ALOANTICORPOS IRREGULARES EM PACIENTES ATENDIDOS NA AGÊNCIA TRANSFUSIONAL DO INI-FIOCRUZ NO CENTRO HOSPITALAR COVID-19 DURANTE O PERÍODO DE PANDEMIA
AG Vizzoni, FRM Silva, AFV Pascoal, JPB Bokel, RE Almeida, DPM Almeida
10.1016/j.htct.2022.09.776
Hematol Transfus Cell Ther. 2022;44 Supl 2:S456
Open access
EVALUATION OF COVID-19 FEAR AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE COVID-19 PANDEMIC
Serhat Çelik, Zeynep Tuğba Güven, Funda İpekten, Muzaffer Keklik, Ali Ünal, Leylagül Kaynar
10.1016/j.htct.2022.09.1213
Hematol Transfus Cell Ther. 2022;44 Supl 1:S16
Open access
ANTIBODY RESPONSES AND SAFETY OF THE COMMERCIALLY AVAILABLE VACCINES AGAINST SARS-COV-2 VIRUS IN ALLOGRAFTED PATIENTS: REAL WORLD DATA FROM A SINGLE CENTER
Panayotis Kaloyannidis, Belal Blowi, Rana Yahya, Hamdah Al Khaldi, Rabab Attas, Afra Dayel, Solaf Kanfar
10.1016/j.htct.2022.09.1216
Hematol Transfus Cell Ther. 2022;44 Supl 1:S17-8
Open access
THE MENTAL HEALTH STATUS OF INPATIENTS WITH NEWLY DIAGNOSED HEMATOLOGICAL CANCER DURING THE COVID-19 PANDEMIC
Ferda CAN, Alperen KORKMAZ, Tekin GUNEY, Sema AKINCI
10.1016/j.htct.2022.09.1217
Hematol Transfus Cell Ther. 2022;44 Supl 1:S18
Open access
CORONAVIRUS ANXIETY LEVEL AND COVID 19 VACCINE ATTITUDE AMONG HEMATOLOGICAL MALIGNANCY PATIENTS
Zeynep Tuğba GÜVEN, Muzaffer KEKLİK, Ali ÜNAL
10.1016/j.htct.2022.09.1218
Hematol Transfus Cell Ther. 2022;44 Supl 1:S18-9
Open access
REAL-LIFE STUDY OF BIO-CLINICAL FOLLOW-UP AFTER BNT162b2 mRNA COVID-19 (BNTCV) VACCINATION IN 235 PATIENTS (PTS) INCLUDING 225 WITH HEMATOLOGICAL MALIGNANCIES (HM).
Jean-François Rossi, Emmanuel Bonnet, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, Roland Sicard, Jean-Pierre Daures, Marion Bonifacy, Lysiane Mousset, Christel Castelli, Emmanuel Goffart
10.1016/j.htct.2022.09.1221
Hematol Transfus Cell Ther. 2022;44 Supl 1:S19-20
Open access
Conteúdo especial sobre COVID-19
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.